
    
      Design An open-label, add-on, self-control clinical trial. Setting Diabetes clinic of a
      teaching hospital in Shenzhen China Participants A total of 20 participants with type 1
      diabetes, aged 18-60 years, will be recruited and treated with metformin as add-on therapy
      with insulin for 12 weeks.

      Outcomes Primary outcomes were glycemic control related parameters, and secondary outcomes
      were anthropomorphic variables, lipid profile, blood pressure and high-sensitivity C-reactive
      protein. The gut microbiota profile will be analyzed before and after intervention .
    
  